Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAdverum Biotechn Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$2.09 | -$0.37 | -$1.24 |
| Q2 2026 | 1 | -$1.21 | -$1.21 | -$1.21 |
| Q3 2026 | 1 | -$1.26 | -$1.26 | -$1.26 |
| Q4 2026 | 1 | -$1.30 | -$1.30 | -$1.30 |
Adverum Biotechn Earnings Date And Information
Adverum Biotechn last posted its earnings results on Wednesday, November 12th, 2025. The company reported $-2.03 earnings per share for the quarter, missing analysts' consensus estimates of $-1.8 by $0.23. The company had revenue of 0 for the quarter and had revenue of 1.00 M for the year. Adverum Biotechn has generated $-7 earnings per share over the last year ($-6.62 diluted earnings per share) and currently has a price-to-earnings ratio of -0.5. Adverum Biotechn has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Adverum Biotechn Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2025 | Q3 2025 | -$1.80 | -$2.03 | -0.23 | $0 | $0 |
| 08/12/2025 | Q2 2025 | -$2.24 | -$2.34 | -0.1 | N/A | $0 |
| 05/14/2025 | Q1 2025 | N/A | -$2.25 | N/A | N/A | $0 |
| 04/15/2025 | Q4 2024 | -$1.81 | -$1.96 | -0.15 | N/A | $0 |
| 11/04/2024 | Q3 2024 | -$1.20 | -$1.30 | -0.1 | $125.00 K | $1.00 M |
| 08/12/2024 | Q2 2024 | -$1.27 | -$0.89 | 0.38 | $106.00 K | $0 |
| 05/09/2024 | Q1 2024 | -$1.28 | -$1.50 | -0.22 | N/A | $0 |
| 03/18/2024 | Q4 2023 | -$2.80 | -$0.41 | 2.39 | N/A | $0 |
| 11/09/2023 | Q3 2023 | -$3.00 | -$0.57 | 2.43 | N/A | $0 |
| 08/10/2023 | Q2 2023 | -$3.20 | -$0.54 | 2.66 | N/A | $0 |
| 05/11/2023 | Q1 2023 | -$3.00 | -$0.50 | 2.5 | N/A | $3.60 M |
| 03/30/2023 | Q4 2022 | -$3.20 | -$0.56 | 2.64 | N/A | $0 |
| 11/10/2022 | Q3 2022 | -$3.20 | -$0.40 | 2.8 | N/A | $0 |
| 08/11/2022 | Q2 2022 | -$3.80 | -$0.44 | 3.36 | N/A | $0 |
| 05/12/2022 | Q1 2022 | -$3.40 | -$0.38 | 3.02 | N/A | $0 |
| 03/29/2022 | Q4 2021 | -$4.20 | -$0.35 | 3.85 | N/A | $0 |
| 11/04/2021 | Q3 2021 | -$4.20 | -$0.39 | 3.81 | N/A | $0 |
| 08/05/2021 | Q2 2021 | -$3.70 | -$0.45 | 3.25 | N/A | $0 |
| 05/06/2021 | Q1 2021 | -$3.80 | -$0.29 | 3.51 | N/A | $7.50 M |
| 03/01/2021 | Q4 2020 | -$3.20 | -$0.39 | 2.81 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Adverum Biotechn Earnings: FAQ's
The conference call for Adverum Biotechn's latest earnings report can be listened to online.
The conference call transcript for Adverum Biotechn's latest earnings report can be read online.
Adverum Biotechn (:ADVM) has a recorded annual revenue of $1.00 M.
Adverum Biotechn (:ADVM) has a recorded net income of $-130,927,000.Adverum Biotechn has generated $-6.62 earnings per share over the last four quarters.
Adverum Biotechn (:ADVM) has a price-to-earnings ratio of -0.5 and price/earnings-to-growth ratio is 0.05.